Free Trial

MediciNova (MNOV) News Today

$1.31
+0.01 (+0.77%)
(As of 07/26/2024 ET)
MediciNova, Inc. (MNOV)
MediciNova logo with Medical background
MediciNova (NASDAQ:MNOV) Now Covered by StockNews.com
StockNews.com assumed coverage on shares of MediciNova in a research report on Thursday. They issued a "hold" rating for the company.
MediciNova logo with Medical background
StockNews.com Initiates Coverage on MediciNova (NASDAQ:MNOV)
StockNews.com assumed coverage on MediciNova in a research note on Wednesday. They issued a "hold" rating on the stock.
MediciNova logo with Medical background
MediciNova, Inc. (NASDAQ:MNOV) Short Interest Update
MediciNova, Inc. (NASDAQ:MNOV - Get Free Report) was the recipient of a significant decline in short interest in the month of June. As of June 15th, there was short interest totalling 110,700 shares, a decline of 18.4% from the May 31st total of 135,600 shares. Approximately 0.2% of the shares of the company are sold short. Based on an average daily volume of 34,200 shares, the days-to-cover ratio is presently 3.2 days.
MediciNova (NASDAQ:MNOV) Receives New Coverage from Analysts at StockNews.com
StockNews.com began coverage on shares of MediciNova in a report on Monday. They set a "hold" rating on the stock.
Short Interest in MediciNova, Inc. (NASDAQ:MNOV) Decreases By 25.5%
MediciNova, Inc. (NASDAQ:MNOV - Get Free Report) was the target of a significant decline in short interest in May. As of May 15th, there was short interest totalling 158,600 shares, a decline of 25.5% from the April 30th total of 212,900 shares. Approximately 0.3% of the company's stock are short sold. Based on an average daily volume of 35,700 shares, the short-interest ratio is presently 4.4 days.
MediciNova (NASDAQ:MNOV) Coverage Initiated by Analysts at StockNews.com
StockNews.com began coverage on MediciNova in a research report on Thursday. They set a "hold" rating on the stock.
MediciNova, Inc. (NASDAQ:MNOV) Short Interest Down 26.0% in April
MediciNova, Inc. (NASDAQ:MNOV - Get Free Report) was the target of a significant decrease in short interest during the month of April. As of April 15th, there was short interest totalling 247,000 shares, a decrease of 26.0% from the March 31st total of 333,600 shares. Based on an average daily volume of 49,400 shares, the days-to-cover ratio is presently 5.0 days. Currently, 0.5% of the shares of the company are sold short.
Medicinova Inc
MediciNova Receives Gene Therapy Milestone Payment
Get MediciNova News Delivered to You Automatically

Sign up to receive the latest news and ratings for MNOV and its competitors with MarketBeat's FREE daily newsletter.

How to build the ultimate dividend portfolio (Ad)

There’s a free dividend workshop that shows how anyone can build the ultimate dividend workshop in 3 basic steps? PLUS: You’ll get the names and tickers of the Best Dividend Stocks for FREE… This way, by the time you finish the workshop you’ll be fully equipped with the knowledge to start unlocking dividend checks for yourself… Over and over again.

Click here and I’ll show you how to build the ultimate dividend portfolio.

MNOV Media Mentions By Week

MNOV Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MNOV
News Sentiment

0.83

0.62

Average
Medical
News Sentiment

MNOV News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MNOV Articles
This Week

3

1

MNOV Articles
Average Week

Get MediciNova News Delivered to You Automatically

Sign up to receive the latest news and ratings for MNOV and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:MNOV) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners